
Categories
Independent Limited Assurance Reports 2022 was a landmark year for GSK. Following the demerger of our Consumer Healthcare business to form Haleon in July, we are now a fully-focused biopharma company. GSK’s purpose is to unite science, technology and talent, and to get ahead of disease together.